Wellness Sanctuary
Home Encyclopedia Articles
Start Metabolic Assessment
Condition Hub

Polycystic Ovary Syndrome (PCOS)

PCOS is fundamentally a metabolic condition driven by systemic insulin resistance, which forces the ovaries to overproduce androgens (testosterone). The clinical goal is to restore insulin sensitivity and normalize ovulatory function.

The Core PCOS Protocol

First-line defense for restoring ovarian signaling.

Primary Target

Myo Inositol Complex (40:1)

40:1 Ratio. The 40:1 Myo to D chiro ratio is non negotiable for follicular health.

The 40:1 ratio mimics physiological follicular fluid levels. It improves insulin sensitivity and reduces LH/FSH ratio imbalances.

Read Full Clinical Review

The 40:1 Clinical Study

Inositol acts as a "second messenger" for insulin. In PCOS, the cell's insulin receptor is essentially "deaf". Clinical studies demonstrate that the exact physiological ratio of 40:1 (Myo Inositol to D Chiro Inositol) repairs this signaling significantly faster than isolated Myo Inositol. It allows glucose to enter the cell, instantly signaling the ovaries to halt androgen overproduction and resume regular ovulation.

Bioavailability Score: 9/10

Secondary Metabolic Support

Insulin Resistance Adjuvant

Berberine Phytosome

Phytosomal Delivery (Berbevis)

  • Maximum glucose stabilization without stomach cramps
  • Significant reduction in late night sugar cravings
  • Improved lipid profile and triglyceride clearance
Read Full Clinical Review →

For severe PCOS cases with marked weight gain or pre-diabetes, Inositol alone may not be enough. Stacking it with Berberine Phytosome activates AMPK (the metabolic master switch), clearing systemic glucose while avoiding the gastrointestinal distress of standard Berberine.